Omeros (OMER) Stock Rallies 149% on $2 Billion Novo Nordisk Deal
admin
The post Omeros The move came after Omeros announced a licensing and asset purchase agreement with Novo Nordisk. The deal centers on zaltenibart, a MASP-3 inhibitor drug candidate formerly called…